|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 17523 |
FusionGeneSummary for INPP5E_SEC16A |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: INPP5E_SEC16A | Fusion gene ID: 17523 | Hgene | Tgene | Gene symbol | INPP5E | SEC16A | Gene ID | 56623 | 9919 |
| Gene name | inositol polyphosphate-5-phosphatase E | SEC16 homolog A, endoplasmic reticulum export factor | |
| Synonyms | CORS1|CPD4|JBTS1|MORMS|PPI5PIV|pharbin | KIAA0310|SEC16L|p250 | |
| Cytomap | 9q34.3 | 9q34.3 | |
| Type of gene | protein-coding | protein-coding | |
| Description | 72 kDa inositol polyphosphate 5-phosphatasephosphatidylinositol polyphosphate 5-phosphatase type IVphosphatidylinositol-4,5-bisphosphate 5-phosphatase | protein transport protein Sec16Aprotein SEC16 homolog A | |
| Modification date | 20180522 | 20180523 | |
| UniProtAcc | Q9NRR6 | O15027 | |
| Ensembl transtripts involved in fusion gene | ENST00000371712, | ENST00000313050, ENST00000467838, ENST00000371706, ENST00000313084, ENST00000290037, ENST00000431893, ENST00000398335, | |
| Fusion gene scores | * DoF score | 4 X 4 X 4=64 | 4 X 4 X 4=64 |
| # samples | 4 | 4 | |
| ** MAII score | log2(4/64*10)=-0.678071905112638 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(4/64*10)=-0.678071905112638 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: INPP5E [Title/Abstract] AND SEC16A [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Tgene | SEC16A | GO:0007029 | endoplasmic reticulum organization | 21768384 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | RV | LUSC | TCGA-56-6546-01A | INPP5E | chr9 | 139328489 | - | SEC16A | chr9 | 139352036 | - |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| Frame-shift | ENST00000371712 | ENST00000313050 | INPP5E | chr9 | 139328489 | - | SEC16A | chr9 | 139352036 | - |
| 5CDS-intron | ENST00000371712 | ENST00000467838 | INPP5E | chr9 | 139328489 | - | SEC16A | chr9 | 139352036 | - |
| 5CDS-intron | ENST00000371712 | ENST00000371706 | INPP5E | chr9 | 139328489 | - | SEC16A | chr9 | 139352036 | - |
| 5CDS-intron | ENST00000371712 | ENST00000313084 | INPP5E | chr9 | 139328489 | - | SEC16A | chr9 | 139352036 | - |
| 5CDS-intron | ENST00000371712 | ENST00000290037 | INPP5E | chr9 | 139328489 | - | SEC16A | chr9 | 139352036 | - |
| 5CDS-intron | ENST00000371712 | ENST00000431893 | INPP5E | chr9 | 139328489 | - | SEC16A | chr9 | 139352036 | - |
| 5CDS-intron | ENST00000371712 | ENST00000398335 | INPP5E | chr9 | 139328489 | - | SEC16A | chr9 | 139352036 | - |
Top |
FusionProtFeatures for INPP5E_SEC16A |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| INPP5E | SEC16A |
| Converts phosphatidylinositol 3,4,5-trisphosphate(PtdIns 3,4,5-P3) to PtdIns-P2, and phosphatidylinositol 4,5-bisphosphate to phosphatidylinositol 4-phosphate. Specific forlipid substrates, inactive towards water soluble inositolphosphates. {ECO:0000269|PubMed:10764818}. | Defines endoplasmic reticulum exit sites (ERES) and isrequired for secretory cargo traffic from the endoplasmicreticulum to the Golgi apparatus. SAR1A-GTP-dependent assembly ofSEC16A on the ER membrane forms an organized scaffold defining anERES. Required for normal transitional endoplasmic reticulum (tER)organization. {ECO:0000269|PubMed:17005010,ECO:0000269|PubMed:17192411}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for INPP5E_SEC16A |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for INPP5E_SEC16A |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| INPP5E | PDE6D, KCTD3, CGN, KIF13B, ZBTB21, KSR1, RALGPS2, GIGYF1, RTKN, MAST3, LPIN3, LRFN1, GIGYF2, CDC25C, DENND4C, NF1, PPM1H, CBY1, SH3RF3, DENND1A, SH3PXD2A, SRGAP2, CAMSAP2, TANC2, PTPN13, EIF4E2, OSBPL6, SIPA1L1, HDAC4, NADK, RASAL2, LIMA1, MAGI1, KIAA1804, TESK2, DCLK1, MAPKAP1, TIAM1, KIF1C, ZNF638, NAV1, PLEKHA7, PHLDB2, STARD13, PTPN14, DENND4A, CWC25, RAB11FIP2, RPTOR, HDAC7, MTFR1L, RPGR, CEP170, DCAF7, YWHAE | SEC16A | NFKB2, TERF1, TERF2, SIRT7, TSG101, CUL3, CAND1, SHC1, VCP, IQCB1, TRAF3, USO1, TRAF2, PAN2, SOX2, HDAC6, HDAC8, HDAC11, ANKRD28, LATS1, LATS2, SAV1, FKBP3, KRT18, CSNK1A1, CSNK1E, CEP250, EMD, CCDC8, RNF2, IRAK1, KLK15, AHNAK, HNRNPH3, NTRK1, MED23, CENPJ, XPO1, AP2A1, C4BPA, CAD, CLTA, CLTB, CLTC, DCTN1, DSP, ERF, GAK, GOLGA2, HNRNPA1, HNRNPK, IMPDH1, IMPDH2, HNRNPM, PFDN2, PIK3C2A, PKP2, PRKAR2A, RBM4, ATXN2, SEC13, TRPS1, VCL, ZKSCAN1, CLTCL1, TNK1, HDAC3, FUBP3, P4HA2, MAP7, BAG3, RBM39, NCOR2, SEC24C, CLINT1, PUM1, SMG7, CAPZA2, CDK2, DBN1, MYH9, PPP1CB, PRKAR2B, PICALM, IQGAP1, SYNPO, MAPRE1, TRIM29, LIMA1, GTSE1, MYO19, CDKN2AIPNL, ELMSAN1, ARX, FAM83H, MYO18A, HELZ, SEC24B, RBM14, SEC23B, SEC23A, SEC24A, PPP1R13L, PKP3, BTBD3, SPG20, FAM120A, KANK2, AKAP8L, PLEKHA5, ANKHD1, FAM120C, PIH1D1, WDR33, BMP2K, KIAA1217, EIF4ENIF1, CCAR2, P3H1, CPSF7, FIP1L1, FAM83D, CHD6, PRRC2B, FAM83A, WDR92, HNRNPUL2, FAM83B, CRY2, MCM2, RC3H1, MYO6, EGFR, EYA2, NEFL, XPNPEP3, AIPL1, PDHA1, BRCA1, YAP1, TES |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for INPP5E_SEC16A |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for INPP5E_SEC16A |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | INPP5E | C0431399 | Familial aplasia of the vermis | 3 | CTD_human;ORPHANET;UNIPROT |
| Hgene | INPP5E | C0008780 | Ciliary Motility Disorders | 2 | CTD_human |
| Hgene | INPP5E | C0015398 | Eye Diseases, Hereditary | 1 | CTD_human |
| Hgene | INPP5E | C0028754 | Obesity | 1 | CTD_human |
| Hgene | INPP5E | C0030846 | Penile Diseases | 1 | CTD_human |
| Hgene | INPP5E | C3714756 | Intellectual Disability | 1 | CTD_human |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|